Biotronics3D

About:

Biotronics3D develops and markets innovative software applications for the diagnostic imaging industry.

Website: http://www.biotronics3d.com

Twitter/X: biotronics3d

Top Investors: Juno Capital Partners, Longbow Capital

Description:

Biotronics3D, headquartered in London, England, develops and markets innovative software applications for the diagnostic imaging industry. They provide cutting edge software technologies to improve healthcare by better extracting diagnostic data and transforming it into usable information available at the point-of-care. Biotronics3D Ltd is an EN ISO 13485:2003 certified company. Their flagship product, 3Dnet Enterprise Suite, has received FDA 510K market clearance and it is CE marked.

Total Funding Amount:

1.2M GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2004-01-01

Contact Email:

info(AT)biotronics3d.com

Founders:

Harry Hatzakis

Number of Employees:

11-50

Last Funding Date:

2015-12-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai